BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
The research of BioMed X team EPD - Early Intervention in Psychiatric Diseases - has shed light on the molecular mechanisms underlying white matter deficits...
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
A new research team at XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and...